Featured Courses

Let’s Smash NASH! Preparing You For the Coming NASH Epidemic

1.50 CME: AGA’s Let’s Smash NASH! program focuses on the link between metabolic syndrome and NAFLD and NASH. Exp 9/19/23

Digital Pathway – Interpreting Data on Novel MR Antagonists and Cardiorenal Outcomes for T2D and CKD

1.00 CME CE: Discusses recent advances with nonsteroidal MRAs in patients with T2D and CKD, as well as their potential application to care. Exp 9/27/23

Clinical Brief: Prevention and Treatment of Influenza in High-Risk Patients with Cardiometabolic Comorbidities

1.00 CME CE: Dr. Gregory Poland leads discussion of connection between influenza and other diseases, particularly its impact on cardiovascular diseases. Exp 6/1/23

Part 2 of 2: Exploring Perspectives in Obesity Management: From Personal Experience to Best Practice

0.50 CME CE: This podcast will explore personal experiences from a person living with obesity, and what providers can do to overcome stigma associated with the disease. Exp 7/28/23

Better Weight Management, Better Outcomes: Practical Approaches to Managing the Interrelated Conditions of Obesity and PCOS

2.00 CME CE: This program is for clinicians interested in the treatment of PCOS and other women’s health challenges related to excess weight or obesity. 6/27/23

Episode 1: Individualized Treatment of the Whole Person with T2D and Application to Cases

0.25 CME: President of the Obesity Society, Dr. Bessesen, uses 2 cases to describe current challenges in the treatment of people with type 2 diabetes. 6/24/23

Episode 2: Incretin Hormone Mythbusters—Unraveling the Role in T2D and Weight Reduction

0.50 CME: Drs. Harold Bays and Daniel Bessesen dispel myths about the role of incretins in type 2 diabetes and weight reduction. 6/24/23

Episode 3: Clinical Trial Data Update for Incretin-Based Therapies in T2D and Obesity

0.50 CME: Learn about incretin-based therapies in the treatment of type 2 diabetes and obesity, including GIP/GLP-1 receptor agonism. 6/24/23

Episode 4: Barrier-Solution—Addressing Weight Reduction for People with T2D and Obesity

0.25 CME: Hear a sample doctor-patient shared decision making conversation on weight reduction in a person with T2D, plus practice tips. 6/24/23

Treating Adult Patients with Growth Hormone Deficiency: Diagnostic Tools and New Treatment Options for Optimal Health

1.50 CME CE: Experts in GHD follow the patient journeys of a young adult transitioning from pediatric care and a 50-year-old patient with AO-GHD. Exp. 6/29/23

How to Initiate the Conversation about Obesity in T2DM Patients

1.00 CME CE: Topics include how to initiate the conversation and address the stigma and bias, and use practical communication strategies. Exp 11/14/23

Advanced Diabetes Technology – Conversations and Collaborations

CME CE 2.00: This course is designed to equip learners with information on how to use diabetes technology and devices. Exp 9/30/23